259 related articles for article (PubMed ID: 10980856)
1. Proarrhythmia, a serious complication of antiarrhythmic drugs.
Podrid PJ
Curr Cardiol Rep; 1999 Nov; 1(4):289-96. PubMed ID: 10980856
[TBL] [Abstract][Full Text] [Related]
2. Aggravation of arrhythmia: a complication of antiarrhythmic drugs.
Podrid PJ
J Cardiovasc Electrophysiol; 1993 Jun; 4(3):311-9. PubMed ID: 8269302
[TBL] [Abstract][Full Text] [Related]
3. [The pro-arrhythmic effects of anti-arrhythmia agents].
Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
[TBL] [Abstract][Full Text] [Related]
4. What have clinical trials taught us about proarrhythmia?
Skanes AC; Green MS
Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
[TBL] [Abstract][Full Text] [Related]
5. Aggravation of arrhythmia: a complication of antiarrhythmic drug therapy.
Podrid PJ
Eur Heart J; 1989 Sep; 10 Suppl E():66-72. PubMed ID: 2680505
[TBL] [Abstract][Full Text] [Related]
6. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.
Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B
Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone and torsades de pointes in patients with advanced heart failure.
Middlekauff HR; Stevenson WG; Saxon LA; Stevenson LW
Am J Cardiol; 1995 Sep; 76(7):499-502. PubMed ID: 7653452
[TBL] [Abstract][Full Text] [Related]
8. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
Hohnloser SH
Am J Cardiol; 1997 Oct; 80(8A):82G-89G. PubMed ID: 9354415
[TBL] [Abstract][Full Text] [Related]
9. Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.
Poser RF; Podrid PJ; Lombardi F; Lown B
Am Heart J; 1985 Jul; 110(1 Pt 1):9-16. PubMed ID: 4013993
[TBL] [Abstract][Full Text] [Related]
10. Proarrhythmia.
Naccarelli GV; Wolbrette DL; Luck JC
Med Clin North Am; 2001 Mar; 85(2):503-26, xii. PubMed ID: 11233957
[TBL] [Abstract][Full Text] [Related]
11. Risks and benefits of antiarrhythmic therapy.
Roden DM
N Engl J Med; 1994 Sep; 331(12):785-91. PubMed ID: 8065408
[No Abstract] [Full Text] [Related]
12. Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs.
Nattel S
Cardiovasc Res; 1998 Mar; 37(3):567-77. PubMed ID: 9659440
[TBL] [Abstract][Full Text] [Related]
13. Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death.
Prystowsky EN
Am J Cardiol; 1996 Oct; 78(8A):35-41. PubMed ID: 8903274
[TBL] [Abstract][Full Text] [Related]
14. Can antiarrhythmic drugs cause arrhythmia?
Podrid PJ
J Clin Pharmacol; 1984 Jul; 24(7):313-9. PubMed ID: 6480877
[TBL] [Abstract][Full Text] [Related]
15. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
16. Proarrhythmia.
Friedman PL; Stevenson WG
Am J Cardiol; 1998 Oct; 82(8A):50N-58N. PubMed ID: 9809901
[TBL] [Abstract][Full Text] [Related]
17. Safety and toxicity of antiarrhythmic drug therapy: benefit versus risk.
Podrid PJ
J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S65-73. PubMed ID: 1723122
[TBL] [Abstract][Full Text] [Related]
18. Proarrhythmic effects of antiarrhythmic drugs: evolving concepts.
Morganroth J
Am Heart J; 1992 Apr; 123(4 Pt 2):1137-9. PubMed ID: 1553883
[TBL] [Abstract][Full Text] [Related]
19. Proarrhythmia: a paradoxic response to antiarrhythmic agents.
McCollam PL; Parker RB; Beckman KJ; Hariman RJ; Bauman JL
Pharmacotherapy; 1989; 9(3):144-53. PubMed ID: 2666959
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced torsade de pointes. Incidence, management and prevention.
Faber TS; Zehender M; Just H
Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
